Patient Derived Xenograft/PDX Models

Patient Derived Xenograft/PDX Models

Future Business Growth Analysis Worth 167.6 Million USD

Priyanka D

Rxamp; D - Biopharmaceutical, Pharmaceutical and Biotechnology Research and Development

The key factors driving the growth of this market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX models is posing a lucrative opportunity in this market.

The PDX models market has been segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models such as head & neck tumors, sarcoma, and melanoma. In 2017, the gastrointestinal tumors segment is expected to account for the largest share of the global PDX models market